Genomic medicine must reduce, not compound, health inequities: the case for hauora-enhancing genomic resources for New Zealand.
暂无分享,去创建一个
S. Robertson | J. Hindmarsh | S. Berry | V. Cameron | M. Cox | O. Dewes | R. Doughty | George Gray | J. C. Jacobsen | Albert Laurence | E. Matisoo-Smith | S. Morton | A. Shelling | Dianne Sika-Paotonu | A. Rolleston | J. Skinner | R. Snell | A. Sporle | C. Print | T. Merriman | M. Hudson | P. Wilcox | J. Jacobsen
[1] J T Hart,et al. THE INVERSE CARE LAW , 1971 .
[2] Anthony E. Reeve,et al. E-cadherin germline mutations in familial gastric cancer , 1998, Nature.
[3] T Ishizaki,et al. High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands. , 1999, Pharmacogenetics.
[4] Charles E. Schwartz,et al. Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans , 2003, Nature Genetics.
[5] A. Sporle,et al. Genetics, race, ethnicity, and health , 2004, BMJ : British Medical Journal.
[6] J. Champagne,et al. Nav1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes. , 2006, The Canadian journal of cardiology.
[7] Rod A Lea,et al. Monoamine oxidase, addiction, and the "warrior" gene hypothesis. , 2007, The New Zealand medical journal.
[8] I. Winship,et al. Cultural enhancement of a clinical service to meet the needs of indigenous people; genetic service development in response to issues for New Zealand Maori , 2007, Clinical genetics.
[9] M. King,et al. Scientific responsibility for the dissemination and interpretation of genetic research: lessons from the “warrior gene” controversy , 2008, Journal of Medical Ethics.
[10] Bruce G. Link,et al. Medical Advances and Racial/Ethnic Disparities in Cancer Survival , 2009, Cancer Epidemiology, Biomarkers & Prevention.
[11] M. Guyer,et al. Charting a course for genomic medicine from base pairs to bedside , 2011, Nature.
[12] Xingyu,et al. The Effect of Chromosome 9 p 21 Variants on Cardiovascular Disease May Be Modified by Dietary Intake : Evidence from a Case / Control and a Prospective Study , 2011 .
[13] M. Benton,et al. Complete Mitochondrial Genome Sequencing Reveals Novel Haplotypes in a Polynesian Population , 2012, PloS one.
[14] R. Lea,et al. HLA and MICA polymorphism in Polynesians and New Zealand Maori: implications for ancestry and health. , 2013, Human immunology.
[15] T. Sammour,et al. Cancer in Māori: lessons from prostate, colorectal and gastric cancer and progress in hereditary stomach cancer in New Zealand , 2013, ANZ journal of surgery.
[16] E. Matisoo-Smith,et al. Hyperuricaemia in the Pacific: why the elevated serum urate levels? , 2014, Rheumatology International.
[17] J. Hindmarsh,et al. Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption , 2013, Arthritis Research & Therapy.
[18] T. Merriman,et al. Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load , 2013, Annals of the rheumatic diseases.
[19] Ajay K. Royyuru,et al. Geographic population structure analysis of worldwide human populations infers their biogeographical origins , 2014, Nature Communications.
[20] G. Shipley,et al. Genetic structure among Fijian island populations , 2015, Journal of Human Genetics.
[21] F. Collins,et al. A new initiative on precision medicine. , 2015, The New England journal of medicine.
[22] D. Goldstein,et al. Unequal representation of genetic variation across ancestry groups creates healthcare inequality in the application of precision medicine , 2016, Genome Biology.
[23] J. Skinner,et al. A Prospective Study of Sudden Cardiac Death among Children and Young Adults. , 2016, The New England journal of medicine.
[24] D. Weeks,et al. A thrifty variant in CREBRF strongly influences body mass index in Samoans , 2016, Nature Genetics.
[25] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[26] Peter Szolovits,et al. Genetic Misdiagnoses and the Potential for Health Disparities. , 2016, The New England journal of medicine.
[27] Zachary A. Szpiech,et al. Challenges and disparities in the application of personalized genomic medicine to populations with African ancestry , 2016, Nature Communications.
[28] E. Ashley. Towards precision medicine , 2016, Nature Reviews Genetics.
[29] E. Burchard,et al. Towards Equity in Health: Researchers Take Stock , 2016, PLoS medicine.
[30] Jonathan Scott Friedlaender,et al. Excavating Neandertal and Denisovan DNA from the genomes of Melanesian individuals , 2016, Science.
[31] Dermot F. Reilly,et al. Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting , 2017, Circulation.
[32] J. Hindmarsh,et al. Population‐Specific Resequencing Associates the ATP‐Binding Cassette Subfamily C Member 4 Gene With Gout in New Zealand Māori and Pacific Men , 2017, Arthritis & rheumatology.
[33] M. Hudson,et al. Engaging Māori in biobanking and genomic research: a model for biobanks to guide culturally informed governance, operational, and community engagement activities , 2016, Genetics in Medicine.
[34] W. Burke,et al. P450 Pharmacogenetics in Indigenous North American Populations , 2018, Journal of personalized medicine.